|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Isradipine#Contraindications]] |
| {{Isradipine}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Contraindications==
| |
| | |
| Isradipine is contraindicated in individuals who have shown hypersensitivity to any of the ingredients in the formulation.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISRADIPINE CAPSULE [COBALT LABORATORIES] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf3425e0-428d-4bdb-ac9a-3b9d483df83a | publisher = | date = | accessdate = 28 February 2014 }}</ref>
| |
| | |
| ==References ==
| |
| {{Reflist|2}}
| |
| | |
| [[Category:Calcium channel blockers]]
| |
| [[Category:Dihydropyridines]]
| |
| [[Category:Benzoxadiazoles]]
| |
| [[Category:Carboxylate esters]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |